MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION
First Claim
1. A method of reducing ANGPTL3 expression in an animal comprising administering to the animal a compound comprising a modified oligonucleotide 10 to 30 linked nucleosides in length targeted to ANGPTL3, wherein expression of ANGPTL3 is reduced by at least 40% in the animal.
1 Assignment
0 Petitions
Accused Products
Abstract
Provided herein are methods, compounds, and compositions for reducing expression of an ANGPTL3 mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions for reducing plasma lipids, plasma glucose and atherosclerotic plaques in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate any one or more of cardiovascular disease or metabolic disease, or a symptom thereof.
36 Citations
65 Claims
- 1. A method of reducing ANGPTL3 expression in an animal comprising administering to the animal a compound comprising a modified oligonucleotide 10 to 30 linked nucleosides in length targeted to ANGPTL3, wherein expression of ANGPTL3 is reduced by at least 40% in the animal.
-
3-7. -7. (canceled)
-
12-28. -28. (canceled)
-
31-33. -33. (canceled)
-
36. (canceled)
-
40. (canceled)
-
41. A method for treating an animal with metabolic or cardiovascular disease comprising
a. identifying said animal with metabolic or cardiovascular disease, b. administering to said animal a therapeutically effective amount of a compound comprising a modified oligonucleotide consisting of 20 linked nucleosides and having a nucleobase sequence comprising at least 8 contiguous nucleobases of a nucleobase sequence selected from any of SEQ ID NO: - 34-182,
wherein said animal with metabolic or cardiovascular disease is treated.
- 34-182,
-
42-48. -48. (canceled)
-
50-53. -53. (canceled)
- 54. A compound comprising a modified oligonucleotide consisting of 10 to 30 linked nucleosides and having a nucleobase sequence comprising at least 8 contiguous nucleobases of a nucleobase sequence selected from any of SEQ ID NO:
-
56-57. -57. (canceled)
-
60. (canceled)
-
63. (canceled)
-
65-71. -71. (canceled)
Specification